The makers of Pradaxa have agreed to pay $3 billion in a settlement to settle lawsuits filed by people harmed by the drug. The proposed settlements will be paid out across roughly 3 and 5 years, depending on how many claims are submitted.
The “pradaxa lawsuit update 2020” is a settlement that was reached in the case of Pradaxa. The settlement includes payouts to those who have been affected by the drug.
Pradaxa, a blood thinner, has been connected to 1,000 deaths and thousands of additional side effects, for which the company has already paid hundreds of millions of dollars in damages.
Some individuals suffered major adverse effects, including bleeding, shortly after the FDA approved it in 2010. Despite the fact that this was a prevalent issue, Pradaxa did not have an antidote for excessive bleeding until October 2015, five years after the drug was initially administered to patients.
According to documents, Pradaxa’s producer, Boehringer Ingelheim, reportedly neglected to inform the FDA that the medicine caused more hemorrhaging after it was approved. Despite the fact that many studies were done, papers show that the corporation only provided the most positive findings for clearance.
Thousands of wrongful death and personal injury cases have been filed as a consequence of Boehringer Ingelheim’s carelessness. You may be eligible to compensation if you or a loved one took Pradaxa and had excessive bleeding. For a no-cost, no-obligation legal consultation, contact us now.
Boehringer Ingelheim Pays $650 Million to Resolve 4,000 Lawsuits (2014)
Wrongful death and personal injury claims were brought soon after Pradaxa was released due to its hazardous side effects. A multidistrict litigation involving 4,000 state and federal cases was filed in August 2012.
Boehringer Ingelheim fought the lawsuit and ended up paying the price. The corporation was fined approximately $1 million in 2013 for discovery violations, including refusal to comply and claimed incompetence in the loss of over 500,000 documents.
Boehringer Ingelheim agreed to pay $650 million to resolve the claims in May 2014, averaging $162,500 per claimant, amid rising public and media criticism.
Hundreds of new lawsuits have been filed against Boehringer Ingelheim.
Despite the fact that there is now an antidote for Pradaxa, Boehringer Ingelheim is nevertheless responsible for the years when patients were at risk of excessive bleeding. Patients who did not get Pradaxa as part of the 2014 settlement have continued to pursue claims. Here are a few instances of what I’m talking about.
Liu Zhensheng (Pending)
Zhensheng Liu died in 2012 after a tumble caused excessive brain hemorrhage. The complaint claims that Pradaxa was to fault, and that Boehringer Ingelheim’s warnings regarding possible adverse effects were inadequate.
The negligent design and testing allegations were rejected by U.S. District Judge William Young in January 2017, but the failure to warn accusation was allowed to go to trial.
Vari, Americo (Pending)
Americo Vari, a Pradaxa patient, died of a cerebral hemorrhage that physicians were unable to stop. Adelaide, Americo’s widow, filed the wrongful death claim, blaming Pradaxa for his death. In August of 2016, a lawsuit was filed in Connecticut.
Linda Castillo and Arnold R. Castillo (Pending)
Pradaxa was given to Arnold Castillo for stroke prevention and systemic embolism. He was harmed by uncontrolled bleeding and the injuries that resulted, but he was able to live. A lawsuit was brought by him and his wife, Linda Castillo, against the corporation.
Princess Fahnestock and her associates (Pending)
A class action lawsuit was launched against Boehringer Ingleheim in Missouri in May 2016. The case, which accuses the firm of crimes connected to the design, production, testing, and advertising of Pradaxa, includes 68 Pradaxa patients and family from Missouri, Delaware, Connecticut, and Ohio.
Keith Love and his associates (Pending)
A class action lawsuit was filed in Missouri in August 2016 on behalf of 76 plaintiffs. Pradaxa is accused of failing to warn, design fault, carelessness, deception, and wrongful death, among other things, according to the complaint.
ClassAction.com can assist you.
If you were not included in the 2014 Pradaxa settlement but were wounded by the medicine before Praxbind was approved, you may be eligible for compensation. Damages for pain and suffering, medical costs, lost earnings, and other financial losses may be recovered in personal injury and wrongful death actions.
Attorneys with ClassAction.com have won wins against huge businesses such as BMW and R.J. Reynolds Tobacco, totaling more than $5 billion for 200,000 clients. For a free, no-obligation legal consultation, contact us now.
The “pradaxa class action lawsuit” is a settlement that has been reached in the case of Pradaxa. The settlement will provide up to $3,000,000 for those who have suffered from serious side effects from the drug.
Frequently Asked Questions
Will Pradaxa be taken off the market?
A: As of now, Pradaxa is still available for purchase.
How long has Pradaxa been on the market?
A: Pradaxa has been on the market for about 10 years.
What company makes Pradaxa?
A: Pradaxa is made by Boehringer Ingelheim.
- pradaxa lawsuit settlement 2021
- pradaxa settlement checks 2021
- pradaxa lawsuit timeline
- latest pradaxa lawsuit news
- pradaxa settlement portal